HUP0200494A2 - Use of-n,n-dimethyl-1-[1-(4 chlorophenyl)cyclobutyl]-3-metilbutilamine for treatment of osteoarthritis - Google Patents

Use of-n,n-dimethyl-1-[1-(4 chlorophenyl)cyclobutyl]-3-metilbutilamine for treatment of osteoarthritis

Info

Publication number
HUP0200494A2
HUP0200494A2 HU0200494A HUP0200494A HUP0200494A2 HU P0200494 A2 HUP0200494 A2 HU P0200494A2 HU 0200494 A HU0200494 A HU 0200494A HU P0200494 A HUP0200494 A HU P0200494A HU P0200494 A2 HUP0200494 A2 HU P0200494A2
Authority
HU
Hungary
Prior art keywords
metilbutilamine
osteoarthritis
cyclobutyl
chlorophenyl
dimethyl
Prior art date
Application number
HU0200494A
Other languages
Hungarian (hu)
Inventor
Carl M Mendel
Timothy B Seaton
Steve P Weinstein
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of HUP0200494A2 publication Critical patent/HUP0200494A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU0200494A 1999-03-19 2000-03-17 Use of-n,n-dimethyl-1-[1-(4 chlorophenyl)cyclobutyl]-3-metilbutilamine for treatment of osteoarthritis HUP0200494A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12530099P 1999-03-19 1999-03-19

Publications (1)

Publication Number Publication Date
HUP0200494A2 true HUP0200494A2 (en) 2002-08-28

Family

ID=22419072

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200494A HUP0200494A2 (en) 1999-03-19 2000-03-17 Use of-n,n-dimethyl-1-[1-(4 chlorophenyl)cyclobutyl]-3-metilbutilamine for treatment of osteoarthritis

Country Status (20)

Country Link
EP (1) EP1169027A4 (en)
JP (2) JP2002539248A (en)
KR (1) KR20020038567A (en)
CN (1) CN1352552A (en)
AU (1) AU773490B2 (en)
BG (1) BG105999A (en)
BR (1) BR0009081A (en)
CA (1) CA2366660A1 (en)
CZ (1) CZ20013284A3 (en)
HK (1) HK1044702A1 (en)
HU (1) HUP0200494A2 (en)
IL (1) IL145238A0 (en)
MX (1) MXPA01009461A (en)
NO (1) NO20014477L (en)
NZ (1) NZ514016A (en)
PL (1) PL365463A1 (en)
SK (1) SK13342001A3 (en)
TR (1) TR200102699T2 (en)
WO (1) WO2000056306A1 (en)
ZA (1) ZA200107682B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821577B (en) * 1981-04-06 1983-03-30 Boots Co Plc Therapeutic agents
ZA836848B (en) * 1982-09-30 1984-05-30 Boots Co Plc Therapeutic agents
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
JP2675573B2 (en) * 1988-03-31 1997-11-12 科研製薬株式会社 Brain function improver
IE61928B1 (en) * 1988-11-29 1994-11-30 Boots Co Plc Treatment of obesity
WO1994000114A1 (en) * 1992-06-23 1994-01-06 Sepracor Inc. Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine
WO1994000047A1 (en) * 1992-06-23 1994-01-06 Sepracor Inc. Methods and compositions for treating depression and other disorders using optically pure (+) sibutramine
JP3862295B2 (en) * 1993-09-30 2006-12-27 独立行政法人理化学研究所 Anti-obesity agent
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
JPH10501238A (en) * 1994-06-01 1998-02-03 アリス ファーマシューティカル コーポレイション Compositions and methods for treating mast cell mediated conditions
GB9619962D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
MA24500A1 (en) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd CARBOXYLIC ACID SALT DERIVATIVE FROM NAPHTHYRIDINE.

Also Published As

Publication number Publication date
CN1352552A (en) 2002-06-05
NZ514016A (en) 2001-09-28
JP2012051904A (en) 2012-03-15
JP2002539248A (en) 2002-11-19
CA2366660A1 (en) 2000-09-28
PL365463A1 (en) 2005-01-10
BR0009081A (en) 2003-03-05
TR200102699T2 (en) 2002-03-21
ZA200107682B (en) 2003-06-18
EP1169027A4 (en) 2004-10-20
KR20020038567A (en) 2002-05-23
IL145238A0 (en) 2002-06-30
CZ20013284A3 (en) 2002-10-16
AU773490B2 (en) 2004-05-27
WO2000056306A1 (en) 2000-09-28
EP1169027A1 (en) 2002-01-09
NO20014477D0 (en) 2001-09-14
NO20014477L (en) 2001-11-01
MXPA01009461A (en) 2004-03-19
HK1044702A1 (en) 2002-11-01
AU3893200A (en) 2000-10-09
BG105999A (en) 2002-06-28
SK13342001A3 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
ZA200202449B (en) Use of retigabin for treating neuropathic pain.
AU2003281978A1 (en) 2,5-diketopiperazines for the treatment of obesity
AU2935200A (en) Compounds for the treatment of obesity
ZA200000450B (en) Bone plate.
IL138784A0 (en) Treatment for diabetes
MX221888B (en) Pesticidal composition for seed treatment.
GB9821217D0 (en) Treatment for substrates
GB9820767D0 (en) Chemical compounds VIII
GB9820753D0 (en) Synthesis of 1,1,1,3,3-Pentafluoropropane
GB2379845B (en) Process for the transfer of data
HK1066219A1 (en) 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
HUP0200501A3 (en) Use of n,n-dimethyl-1-[1-(4chlorophenyl)cyclobutyl]-3-methylbutylamine for treating sleep apnoea
IL142557A0 (en) Remedies for bone metabolic errors
HUP0103303A3 (en) Imidazole compounds, process for producing them, their use and medicaments containing them
HUP0200494A2 (en) Use of-n,n-dimethyl-1-[1-(4 chlorophenyl)cyclobutyl]-3-metilbutilamine for treatment of osteoarthritis
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
IL149507A0 (en) 3-(4,5-dihydroisoxazole-5-yl) benzoylpyrazole
IL143586A0 (en) Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
HUP0201110A3 (en) Process for preparing 3,5-difluoroaniline
MXPA03002926A (en) Process for the synthesis of 2,2,6,6-tetramethyl-4-oxopiperidine.
IL147830A0 (en) Process for the preparation of acylated 1,3-dicarbonyl compounds
HUP0005004A3 (en) Process for the manufacture of sulfonylaminocarbonyl triazolinone salts
HUP0103778A3 (en) Process for preparing 1,5-diaryl-3-substituted pyrazoles
ZA991786B (en) Therapeutic treatment for asthma.
ZA200102818B (en) Process for the preparation of 4,4'-dihalogen-O-hydroxydiphenyl compounds.